US Equities Analysis

BAX — Baxter International

Research evidence pack

Source-backed valuation visuals

Loading verified snapshot
Loading verified market, valuation, and statement data.

2. Company Fundamentals

2.1 Competitiveness

Metric Value
Operating Margins 6.03%
Profit Margins -9.7%
Return on Equity -15.01%
Return on Assets 2.85%
Free Float 0.51B
Dividend Yield 0.91%
Short Int % Utilisation 12.96%

2.2 Growth

Metric Value
Revenue Growth 2.9%
Free Cash Flow 0.9B
EBITDA 9.5 (Ratio)
Enterprise Value 18.13B
EV/Revenue 1.6
EV/EBITDA 9.5

Revenue growth of 2.9% suggests mature or challenged top-line momentum.

2.3 Management

Role Metric
Consensus Rating N/A

2.4 Return

Metric Value
Expected Return (Ann.)* 22.97%
Risk / Std Dev (Ann.)* 43.66%
1-Year Price Return* 11.49%

Latest Market Data (as of 2026-08-14, US Eastern time):

Metric Value
Last Price $26.73
52-Week Range $15.73 – $30.00
Observation Count 251 trading days

The return and risk statistics use daily adjusted closes from the retrieved one-year series and annualise daily moments using 252 trading days. The last price is the latest regular-market price reported for the stated date. Source: Yahoo Finance market data.

2.5 FCFF DCF Valuation

FCFF DCF exception: Reported operating inputs do not support a stable FCFF DCF. This post deliberately does not publish a mechanical enterprise value or implied per-share value on an unsuitable basis.

Available valuation input Value
Last market price $25.83
Market capitalisation $13.36B
Revenue $11.24B
EBIT -$215.00M
Reported free cash flow $323.00M
FCF yield 2.42%
Net debt / EBITDA 10.20x

2.6 Investor-Style Research Screen

Educational screen Result
Buffett-inspired cash-quality checks not rated — FCFF DCF suitability or data-integrity condition not met
Lynch-inspired balance-and-growth checks not rated — FCFF DCF suitability or data-integrity condition not met

Data lineage: Yahoo Finance public market and reported-statement data; retrieval timestamp: 2026-08-18 17:24:05.825374 UTC; latest reported fiscal period: 2025-12-31 00:00:00. Financial institutions and REITs require sector-specific methods rather than a mechanical FCFF DCF. This is research and analysis only, not personalized financial advice.

us-equity stock equity bax health-care health-care-equipment nasdaq